Oppenheimer & CO Inc Neoleukin Therapeutics, Inc. Transaction History

Oppenheimer & CO Inc

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 02, 2022	SELL	$4.65 - $7.75 $70,642 - $117,738	-15,192 Closed	0 $0
Q3 2021 Nov 12, 2021	BUY	$6.05 - $9.66 $6,158 - $9,833	1,018 Added 7.18%	15,192 $110,000
Q2 2021 Aug 03, 2021	SELL	$9.23 - $13.12 $2,916 - $4,145	-316 Reduced 2.18%	14,174 $131,000
Q1 2021 May 10, 2021	BUY	$11.26 - $15.78 $844 - $1,183	75 Added 0.52%	14,490 $178,000
Q4 2020 Feb 11, 2021	BUY	$10.17 - $14.56 $6,763 - $9,682	665 Added 4.84%	14,415 $203,000
Q3 2020 Nov 13, 2020	BUY	$9.68 - $17.01 $133,100 - $233,887	13,750 New	13,750 $165,000

199K

Ticker NLTX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 42,579,900
Description
Neoleukin Therapeutics, Inc., a biopharmaceutical company, develops immunotherapies for cancer, inflammation, and autoimmunity disorders using protein design technology. The company's lead product candidate is NL-201, a de novo protein designed to mimic the therapeutic activity of the cytokines interleukin (IL)-2/IL-15 for the treatment of vario...

Get notified when there are updates to the investment portfolio of Oppenheimer & CO Inc, based on Form 13F filings with the SEC.

Stay updated on Oppenheimer & CO Inc with notifications on news.